CorEx
Reveal, Assure, Decide
CorEx is a comprehensive CCTA analysis tool, a deep-learning point-of-care solution that automatically identifies and classifies coronary lesions based on CCTA scans. CorEx also calculates lesion related FFR value, enabling optimal patient management, in less than one minute.
CCTA is recommended by the ESC and the AHA as the first line test for patients with stable chest pain with the strongest level of evidence.
Ischemia assessment (FFR ≤ 0.8 threshold) is required to make a revascularization decision.
An AI prediction from a CT scan can be useful for the diagnosis of vessel specific ischemia and may avoid this invasive examination, that, in a majority of cases, leads to unnecessary downstream angioplasty procedures.



CAD RADS
CorEx automatically classifies lesions (stenoses) according to the international CAD-RADS classification, helping to choose optimal treatment for the patient
FFR AI
Corex provide an estimation of the Fractional Flow Reserve (FFR) in less than a minute. This analysis doesn’t require any core lab intervention.
The measurement of FFR is used to determine the need for revascularization by stent or bypass.
This analysis helps to reduce diagnostic ICA numbers by
increasing cardiologists and radiologists confidence in their diagnostic.






Technology
Spimed-AI leverages powerful artificial intelligence models trained on over 10,000 expertly annotated medical scans.
Our technology enables highly accurate detection of coronary lesions and advanced 3D vessel modeling.
Unlike traditional methods such as Computational Fluid Dynamics (CFD), our technology delivers near-instant results without compromising precision. It streamlines image interpretation, shortens diagnostic timelines, and enhances clinical decisions.
Backed by two patents, the solution is GDPR-compliant, clinically validated, and is already CE certified under the MDD regulation.
